Grants & Projects per year
Fingerprint
Dive into the research topics where Michael Schuster is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
GO44900: A Phase Ib Study Evaluating Safety Efficacy Pharmacokinetics & Pharmacodynamics of Glofitamab in Comination with Gemcitabine plus Oxaliplatin in Patients from Racial-Ethnic Minorities with Relapsed or Refractory Diffuse Cell Lympho
Gabig, T. (CoI), Jandl, T. (CoI), Lan, F. (CoI), Lee, C. (CoI), Liu, S. (CoI) & Schuster, M. (CoI)
05/1/26 → 01/28/27
Project: Research
-
Ntrust-2: A Phase 1 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy in Subjects with Immune-Mediated Diseases
Schuster, M. (PI), Gabig, T. (CoPI), Jandl, T. (CoPI), Lan, F. (CoPI), Lee, C. (CoPI) & Liu, S. (CoPI)
05/5/25 → 02/3/27
Project: Research
-
GO43878: A Phase III, Open-label, Multicenter, Randomized Study Evaluating Glofitamab as a Single Agent Versus Investigator's Choice in Patients With Relapsed/Refractory Mantle Cell Lymphoma
Gabig, T. (CoI), Jandl, T. (CoI), Lan, F. (CoI), Lee, C. (CoI), Liu, S. (CoI) & Schuster, M. (CoI)
06/26/26 → 08/29/26
Project: Research
-
Ntrust-1: A Phase 1 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy, in Subjects with Autoimmune Disease
Yao, Q. P. (PI), Gabig, T. (CoPI), Jandl, T. (CoPI), Lan, F. (CoPI), Lee, C. (CoPI), Liu, S. (CoPI) & Schuster, M. (CoPI)
05/16/25 → 08/19/26
Project: Research
-
ICT-8 Efficacy Study of Inecalcitol in Combination with Decitabine in Acute Myeloid Patients Unfit for Standard Chemotherapy
Gabig, T. (CoPI), Lan, F. (CoPI), Schuster, M. (CoPI), Salman, H. (PI) & Kiner-Strachan, B. (CoPI)
10/27/17 → 08/2/19
Project: Research
-
Burixafor, a CXCR4 inhibitor with a differentiated kinetics profile: results of a phase 2 study for rapid cell mobilization in multiple myeloma and lymphoma patients undergoing transplant
Sukhtankar, D. D., Cardarelli, P. M., Jalilizeinali, B., Setia, G., Kim, G. Y., Chang, L. W., Tsai, C. Y., Caculitan, N. G. & Schuster, M. W., Mar 2026, In: Annals of Hematology. 105, 3, 86.Research output: Contribution to journal › Article › peer-review
Open Access -
Daratumumab-bortezomib-cyclophosphamide-dexamethasone for newly diagnosed amyloidosis: ANDROMEDA final survival analysis
ANDROMEDA Trial Investigators, 2026, (Accepted/In press) In: Blood.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Systematic Review of Chimeric Antigen Receptor T-cell Therapy in Autoimmune Diseases
Hershkowitz, N., Andrzejczyk, A., DeStefano, V., Schuster, M. & Yao, Q., Aug 2026, In: Journal of Clinical Rheumatology. 32, 5, p. e173-e181Research output: Contribution to journal › Review article › peer-review
-
A Relapsed AML Case Featuring MYC and MECOM Rearrangements
Murgas, K. A., Materum, P., Li, L. Z., Rocha, J., Schuster, M., Ahmed, T. & Tirado, C. A., Sep 2025, In: Diagnostics. 15, 18, 2410.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Randomized Phase III SIERRA Trial of 131I-Apamistamab before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML
Gyurkocza, B., Nath, R., Seropian, S., Choe, H., Litzow, M. R., Abboud, C., Koshy, N., Stiff, P., Tomlinson, B., Abhyankar, S., Foran, J., Hari, P., Chen, G., Al-Kadhimi, Z., Kebriaei, P., Sabloff, M., Orozco, J. J., Jamieson, K., Silverman, M. & Van Besien, K. & 20 others, , Jan 10 2025, In: Journal of Clinical Oncology. 43, 2, p. 201-213 13 p.Research output: Contribution to journal › Article › peer-review
Open Access15 Scopus citations